A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)
Clinical trial NCT04778800 · UNKNOWN
Trial details
- NCT number
- NCT04778800
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-20
- Primary completion
- 2023-02-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.